Fig. 2: Distribution of WHO-defined pretreatment drug resistance in the ADVANCE trial, using the WHO Surveillance Drug Mutations list for mutations detected at >20% of the viral quasispecies.
Error bars indicate 95% confidence intervals around the proportion estimates.
